{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:439260",
      "entity_text" : "noradrenaline",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:7010534",
      "entity_text" : "Li",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Thus, Li et al. have shown that oral administration of Almorexant in the conscious SHR reduces mean arterial blood pressure (~ 30 mmHg), heart rate and plasma noradrenaline during both wakefulness and NREM sleep, but has no significant effect in normotensive WKY rats.",
  "reading_complete" : "2020-08-05T20:28:51Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-05T20:26:30Z",
  "trigger" : "reduces",
  "evidence" : [ "Li et al.               have shown that oral administration of Almorexant in the conscious SHR reduces mean arterial blood pressure (~30 mmHg), heart rate and plasma noradrenaline" ],
  "pmc_id" : "3874580",
  "score" : 0
}